JOHNSON & JOHNSON — Director's Dealing 2020

Feb 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2020-02-03

Reporting Person: Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-03	Common Stock	M	48312.0000	—	Acquired	123450.0010	Direct
2020-02-03	Common Stock	F	23721.0000	$149.3200	Disposed	99729.0010	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-03	Restricted Share Units	$	M	48312.0000	Disposed		Common Stock (48312.0000)	Direct

Footnotes

F1: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 1, 2017; converted into shares of Common Stock upon vesting.

F2: Shares withheld for payment of taxes upon vesting of Restricted Share Units.